share_log

UroGen Pharma Ltd | 8-K: UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025

UroGen Pharma Ltd | 8-K: UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025

乌龙制药 | 8-K:UroGen Pharma 公布 2024 年第三季度财务业绩和业务亮点,包括可能在 2025 年推出 UGN-102
美股SEC公告 ·  11/06 21:07
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息